FOXO Agrees to Acquire Preferred Stock in Ludwig Enterprises

FOXO Technologies Inc. signed agreements to acquire preferred stock carrying majority voting power and certain notes from Ludwig Enterprises. Ludwig is developing a non-invasive mRNA biomarker testing platform called Revealia.